ERS Genomics and Cellecta, Inc. Sign License Agreement on CRISPR/Cas9 Genome Editing Patents for Tools and Services
Friday, 10 November 2017 () ERS Genomics Ltd. and Cellecta, Inc. announced today a non-exclusive license agreement to provide Cellecta with worldwide access to ERS Genomics' CRISPR/Cas9 genome editing intellectual property f...
Zymeworks Inc. (ZYME) announced Monday morning that it has entered into a licensing agreement with Janssen Biotech Inc., one of the Janssen Pharmaceutical... RTTNews - MarketsAlso reported by •Marketwired •Business Wire •PR Newswire Asia
The agreement is effective as of November 15, 2017
WILMINGTON, Del. (PRWEB) November 10, 2017
DuPont and Giga Solar Materials Corporation announced today... PRWeb - Press ReleasesAlso reported by •Marketwired